IQVIA (IQV)

• Market cap: $37.6B
• 1 day: -1.32%
• 5 days: 3.48%
• 1 month: 7.74%
• 3 months: 16.48%
• 6 months: 55.56%
• Year to date: 13.06%
• 1 year: 8.71%
• 5 years: 26.98%
• 10 years: 228.34%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Employees: 91,000